In this roundtable, Graham Bond and Laragh Jeanroy, co-heads of life sciences, will be joined by R&D specialists, James Tetley and Lizzie Gosling, to explore the practical impact of the changes, how you can plan and forecast, or even consider how to adjust your business model to mitigate the impact on cash flow.
We will be discussing the following topics:
• re-introduction of a PAYE cap for the SME regime;
• change to a territorial basis on R&D claims, limiting both SME and RDEC relief on R&D undertaken outside the UK; and
• increased compliance requirements.
Why you should attend
This is an opportunity for senior decision makers within the Life Sciences and Biotech industry to discuss and share their questions, experiences and views. We encourage the conversation to be free flowing amongst the group.
Register for the event here: Roundtable: Life Sciences R & D reliefs - the biggest changes since 2000 | RSM UK
If you have any questions please contact Rosalind Pontifex.
We will use your personal information to give you access to the webinar. We will also analyse your use of our content and use any feedback that you provide to improve future sessions and other marketing content. For more info about how we handle your personal information, see our privacy policy. For more info about how ON24 collects and uses your data, including their use of cookies, see their privacy policy.By registering, you consent to the ON24 cookies